Interpreter of Maladies: Application of Machine Learning to Precision Oncology
In this webinar, Emory University’s Dr. Anant Madabhushi will share how radiomic and pathomic approaches (derived from machine learning tools) can help predict disease outcome, recurrence, progression, and therapy response in the context of cancer.
Such approaches can assist your work in:
- prostate cancer.
- brain cancer.
- rectal cancer.
- oropharyngeal cancer.
- lung cancer.
Dr. Madabhushi and his team have been developing computerized knowledge alignment, representation, and fusion tools for integrating and correlating heterogeneous biological data. Such machine learning tools are valuable for precision oncology.
Dr. Madabhushi is a professor at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. He also serves as executive director at the Emory Empathetic Artificial Intelligence (AI) for Health Institute. His team applies AI, radiomics, computational pathology, medical image analysis, and computer vision to the diagnosis, prognosis, and prediction of treatment responses across diseases (including cancer).
Upcoming Events
- Envisioning a Future Toward More Equitable Trials: Artificial Intelligence and Its Implications in Health EquitySeptember 09, 2024 - September 10, 2024Impact of the Molecular Characterization Initiative on Pediatric CNS TumorsSeptember 10, 2024AI and Global OncologySeptember 24, 2024NCI’s Clinical and Translational Data Commons: Your Resource for Cancer DiscoverySeptember 25, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024